# Analyzing the genetic profile of autistic children and adolescents with minimal verbal abilities

**Authors:** Silvia Guerrera, Ilaria Venezia, Maria Grazia Logrieco, Laura Casula, Rossella Capolino, Maria Cristina Digilio, Maria Lisa Dentici, Marina Macchiaiolo, Federico Casciani, Fabiana Cortellessa, Lorenzo Sinibaldi, Andrea Bartuli, Silvia Di Tommaso, Gemma D'Elia, Viola Alesi, Cristina Roberti, Antonio Novelli, Giovanni Valeri, Stefano Vicari

PMC · DOI: 10.3389/fgene.2026.1647481 · Frontiers in Genetics · 2026-02-04

## TL;DR

This study finds that 22.6% of minimally verbal autistic individuals have a genetic disorder, which is higher than the general autistic population, and suggests that those without genetic causes may have unique characteristics affecting their condition.

## Contribution

The study is the first to analyze genotype-phenotype correlations in minimally verbal autistic individuals and reports a doubled prevalence of genetic syndromes compared to the general autistic population.

## Key findings

- 22.6% of minimally verbal autistic individuals had a detectable genetic disorder, twice the rate of the general autistic population.
- Autism severity was higher in those without genetic causes, particularly in Total Comparison Score on ADOS-2.
- No significant differences were found in cognitive, adaptive functioning, or behavioral characteristics between the two groups.

## Abstract

Comprehensive care for autistic youth with severe symptoms and language impairment includes genetic testing to find underlying causes. Identifying a genetic diagnosis helps determine prognosis, guide treatment, assess recurrence risk, and connect families with targeted resources and support networks.

This cross-sectional study analyzed retrospectively data of a cohort of 60 Autism Spectrum Disorder Minimally Verbal (MV) past age 5 children and adolescents who underwent several genetic investigations and were included in an evaluation protocol including cognitive, adaptive, psychiatric, parental stress and autism characteristics’ evaluations to identify whether there were any specific clinical or genetic characteristics in the group of minimally verbal autistic individuals.

The percentage of genetic disorders detected in the series is 22.6%. Two groups of MV autistic individuals were defined: those without a known genetic cause (n = 46, neuropsychological data available for 32 individuals) and those with an associated genetic condition (n = 14, neuropsychological data available for 8 individuals). Most participants in both groups scored below 70 on Nonverbal Intelligence Quotient (NVIQ) (77.5% in the first group versus 77.7% in the latter) and adaptive functioning was impaired in both groups, without significant differences. Autism severity, measured by the ADOS-2, was significantly higher in individuals without causative alteration, particularly in Total Comparison Score. However, no differences were found between groups in restricted and repetitive behaviors. CBCL showed high levels of internalizing and externalizing problems in both groups, with no differences. Similarly, parental stress levels were high in both groups.

This is the first study analyzing the genotype-phenotype correlation in MV autistic individuals. In this sample, the prevalence of genetic syndromes was found to be twice as high as in the general autistic population (22.6% versus 10%). Regarding the autistic characteristics’ severity which appear to be higher in individuals without genetic causative alteration and the absence of significant differences in cognitive, functional and behavioural characteristics, we hypothesised that, in the MV autistic population without genetic causative alteration, there are specific and unknown characteristics of the MV profile which have a greater impact than the individual genetic condition reported.

## Linked entities

- **Diseases:** Autism Spectrum Disorder (MONDO:0005258)

## Full-text entities

- **Genes:** Cntnap2 (contactin associated protein-like 2) [NCBI Gene 66797] {aka 5430425M22Rik, Caspr2, mKIAA0868}, NF1 (neurofibromin 1) [NCBI Gene 4763] {aka NFNS, VRNF, WSS}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, KAT6A (lysine acetyltransferase 6A) [NCBI Gene 7994] {aka ARTHS, MOZ, MRD32, MYST-3, MYST3, RUNXBP2}, FMR1 (fragile X messenger ribonucleoprotein 1) [NCBI Gene 2332] {aka FMRP, FRAXA, POF, POF1}, Foxp2 (forkhead box P2) [NCBI Gene 114142] {aka 2810043D05Rik, CAG-16, D0Kist7}, FOXP2 (forkhead box P2) [NCBI Gene 93986] {aka CAGH44, SPCH1, TNRC10}, Shank3 (SH3 and multiple ankyrin repeat domains 3) [NCBI Gene 58234] {aka Spank-2, proSAP2}, PBX1 (PBX homeobox 1) [NCBI Gene 5087] {aka CAKUHED}, GLI3 (GLI family zinc finger 3) [NCBI Gene 2737] {aka ACLS, GCPS, GLI3-190, GLI3FL, PAP-A, PAPA}, TBR1 (T-box brain transcription factor 1) [NCBI Gene 10716] {aka AUTS5, IDDAS, TBR-1, TES-56}, TNPO2 (transportin 2) [NCBI Gene 30000] {aka IDDHISD, IPO3, KPNB2B, TRN2}, SHANK3 (SH3 and multiple ankyrin repeat domains 3) [NCBI Gene 85358] {aka DEL22q13.3, PROSAP2, PSAP2, SCZD15, SPANK-2}, DMPK (DM1 protein kinase) [NCBI Gene 1760] {aka DM, DM1, DM1PK, DMK, MDPK, MT-PK}, PTEN (phosphatase and tensin homolog) [NCBI Gene 5728] {aka 10q23del, BZS, CWS1, DEC, GLM2, MHAM}
- **Diseases:** major (MESH:D004830), MV (MESH:D001039), syndrome (MESH:D013577), duplication syndrome (MESH:D058674), growth retardation (MESH:D006130), achilles tendons (MESH:D052256), death (MESH:D003643), externalizing problems (MESH:D017577), lack of (MESH:D001259), CFC (MESH:C535579), CS (MESH:D006223), sleep disturbance (MESH:D012893), ID (MESH:D008607), ASD (MESH:D000067877), Rett syndrome (MESH:D015518), brain (MESH:D001927), Neurofibromatosis (MESH:D017253), Angelman syndrome (MESH:D017204), CDI (MESH:D020790), Costello syndrome (MESH:D056685), Stress (MESH:D000079225), epilepsy (MESH:D004827), dysmorphic features (MESH:D000013), hypotonia (MESH:D009123), condition (MESH:D020763), hypoplasia (MESH:D000080344), respiratory infections (MESH:D012141), anxiety (MESH:D001007), developmental impairments (MESH:D007805), Myotonic Dystrophy type 1 (MESH:D009223), impairments in reciprocal social behavior (MESH:D054139), congenital heart defects (MESH:D006330), syringomyelia (MESH:D013595), developmental delayIDDAS (MESH:C567924), papillomata of the face and (MESH:C536384), febrile seizures (MESH:D003294), Autism (MESH:D001321), Mendelian disorder (MESH:D025861), Arboleda-Tham (OMIM:616268), cancer (MESH:D009369), Kleefstra Syndrome (MESH:C563043), Vertebral anomalies (MESH:C535781), weakness (MESH:D018908), DS (MESH:D004314), tuberous sclerosis 2 (MESH:C566021), gastrointestinal abnormalities (MESH:D005767), Mental Disorders (MESH:D001523), AD (MESH:D000544), transitional cell carcinoma of the bladder (MESH:D002295), PMS (MESH:C536801), SC (MESH:D006450), learning disabilities (MESH:D007859), ulnar deviation of the wrists and fingers (MESH:D017769), NS (MESH:D056770), cardiac hypertrophy (MESH:D006332), functioning (MESH:D003291), loss of skills (MESH:D019957), genital defects (MESH:D014564), kidney disease (MESH:D007674), depression (MESH:D003866)
- **Chemicals:** EDTA (MESH:D004492)
- **Species:** Homo sapiens (human, species) [taxon 9606], Mus musculus (house mouse, species) [taxon 10090]
- **Mutations:** c.4818_4819insA, p.Glu1608fs, p.E37dup, c.926C>T, c.697C>T, p.Tyr632Ter, c.4663-7_4663-1delCCCACAG, c.121C>T, c.1896C>G, c.108_110dupAGA, c.3677del

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12914954/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12914954/full.md

## References

126 references — full list in the complete paper: https://tomesphere.com/paper/PMC12914954/full.md

---
Source: https://tomesphere.com/paper/PMC12914954